Table 3

HRQoL outcome across individual processes-of-care, for those reporting it as having been performed (+) or not (−)

 Health-related quality of life measures
 Mean (SD)Mean (SD)
PoC not reported (−)PoC reported (+)p Value*
Lipids
 SF-12 MCS48.4 (9.1)46.9 (11.3)0.68
 SF-12 PCS42.2 (11.8)43.5 (10.5)0.76
 ADDQoL−1.5 (1.4)−1.6 (1.6)0.77
Urine microalbumin
 SF-12 MCS46.6 (11.4)47.4 (11.1)0.54
 SF-12 PCS41.6 (9.8)44.0 (10.6)0.12
 ADDQoL−1.5 (1.5)−1.6 (1.6)0.48
Foot examination
 SF-12 MCS46.7 (11.0)47.2 (11.2)0.66
 SF-12 PCS44.1 (9.0)43.1 (11.2)0.59
 ADDQoL−1.5 (1.4)−1.6 (1.6)0.72
Retinal eye examination
 SF-12 MCS47.8 (10.6)46.9 (11.3)0.39
 SF-12 PCS43.8 (11.0)43.2 (10.5)0.38
 ADDQoL−1.2 (1.5)−1.7 (1.6)0.01
Hemoglobin A1c†
 SF-12 MCS42.0 (10.1)46.6 (11.6)0.64
 SF-12 PCS30.0 (14.9)43.7 (10.9)0.18
 ADDQoL−2.8 (0.98)−1.8 (1.7)0.01
Flu vaccinationp value‡
 SF-12 MCS47.4 (10.9)46.8 (11.3)0.58
 SF-12 PCS46.2 (9.9)41.8 (10.6)0.000
 ADDQoL−1.3 (1.3)−1.7 (1.7)0.001
  • *F-test for ANOVA.

  • †Results displayed for HbA1c-aware patients only.

  • ‡Two sample t tests with equal variances.

  • ADDQoL, Audit of Diabetes-Dependent Quality of Life; ANOVA, analysis of variance; HbA1c, glycated hemoglobin; MCS, mental composite score; PCS, physical composite score; PoC, processes-of-care; SF-12, short form-12.